ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 147 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2015. The put-call ratio across all filers is 2.13 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $6,000 | -33.3% | 1,500 | 0.0% | 0.01% | -28.6% |
Q2 2019 | $9,000 | +50.0% | 1,500 | 0.0% | 0.01% | +40.0% |
Q1 2019 | $6,000 | +100.0% | 1,500 | 0.0% | 0.01% | +150.0% |
Q4 2018 | $3,000 | – | 1,500 | +1400.0% | 0.00% | – |
Q1 2018 | $0 | – | 100 | 0.0% | 0.00% | – |
Q4 2017 | $0 | -100.0% | 100 | 0.0% | 0.00% | – |
Q3 2017 | $1,000 | 0.0% | 100 | -50.0% | 0.00% | – |
Q2 2017 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
Q1 2017 | $1,000 | -75.0% | 200 | -72.4% | 0.00% | -100.0% |
Q4 2016 | $4,000 | +300.0% | 724 | +262.0% | 0.00% | – |
Q3 2016 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
Q2 2016 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
Q1 2016 | $1,000 | -80.0% | 200 | -66.7% | 0.00% | -100.0% |
Q4 2015 | $5,000 | +150.0% | 600 | +177.8% | 0.00% | +200.0% |
Q3 2015 | $2,000 | – | 216 | +575.0% | 0.00% | – |
Q2 2015 | $0 | -100.0% | 32 | -89.8% | 0.00% | -100.0% |
Q1 2015 | $3,000 | 0.0% | 315 | -37.0% | 0.00% | 0.0% |
Q4 2014 | $3,000 | – | 500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 9,709,607 | $60,394,000 | 3.07% |
MSD Partners, L.P. | 3,410,500 | $21,213,000 | 1.32% |
MILLER VALUE PARTNERS, LLC | 4,926,456 | $30,643,000 | 1.24% |
Michael & Susan Dell Foundation | 66,749 | $415,000 | 0.33% |
ACUTA CAPITAL PARTNERS, LLC | 150,000 | $933,000 | 0.26% |
Piermont Capital Management Inc. | 85,500 | $532,000 | 0.15% |
A.R.T. Advisors, LLC | 411,547 | $2,559,000 | 0.14% |
EQUITEC PROPRIETARY MARKETS, LLC | 96,100 | $598,000 | 0.14% |
Vident Investment Advisory, LLC | 204,744 | $1,274,000 | 0.10% |
EQUITEC PROPRIETARY MARKETS, LLC | 68,800 | $428,000 | 0.10% |